Door Stefan , laatste wijziging: 03-07-2025
Consider proactively contacting patients who are eligible for funded treatment, including Mori and Pacific patients, and those with renal or cardiovascular complications This MedCase was written by Dr Vicki Mount, BSC/BCom, MBChB, MRNZCGP, DipPaeds, with expert review by Dr Ryan Paul (BHB, MBChB, FRACP, PhD) References Recognition of Learning Activities Don't forget to log your time with The Royal New Zealand College of General Practitioners portal for recognition of learning activities.
Similarly, Mounjaro is FDA-approved for diabetes, while its twin drug Zepbound is approved for obesity
Consult with a licensed healthcare provider before using any peptide supplement
Designing a dual GLP-1R/GIPR agonist from Tirzepatide: comparing residues between Tirzepatide, GLP-1, and GIP